These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 8237260)
21. [Diagnostic validity of anti-tissue transglutaminase and anti-endomysium antibodies in children with celiac disease]. Matusiewicz K; Iwańczak B; Matusiewicz M; Iwańczak F Pol Merkur Lekarski; 2006 Jan; 20(115):17-21. PubMed ID: 16617728 [TBL] [Abstract][Full Text] [Related]
22. Positive tissue transglutaminase antibodies with negative endomysial antibodies: low rate of celiac disease. Weiss B; Bujanover Y; Avidan B; Fradkin A; Weintraub I; Shainberg B Isr Med Assoc J; 2004 Jan; 6(1):9-12. PubMed ID: 14740501 [TBL] [Abstract][Full Text] [Related]
23. [Class IgA antigliadin antibodies and monitoring of compliance to gluten-free diet in celiac disease]. Volta U; Molinaro N; Fratangelo D; Bianco Bianchi F Ann Ital Med Int; 1990; 5(2):112-7. PubMed ID: 2248858 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of celiac disease among blood donors in Brazil. Gandolfi L; Pratesi R; Cordoba JC; Tauil PL; Gasparin M; Catassi C Am J Gastroenterol; 2000 Mar; 95(3):689-92. PubMed ID: 10710058 [TBL] [Abstract][Full Text] [Related]
25. [Transglutaminase antibody: usefulness in the diagnosis of celiac disease]. Palacios Sarrasqueta M ; Rivero Marcotegui A ; SánchezValverde Visus F ; Feijoo Blanco E ; Ramos Arroyo M ; Olivera Olmedo J ; García Merlo S An Esp Pediatr; 2000 Dec; 53(6):542-6. PubMed ID: 11148151 [TBL] [Abstract][Full Text] [Related]
26. Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease. Sugai E; Vázquez H; Nachman F; Moreno ML; Mazure R; Smecuol E; Niveloni S; Cabanne A; Kogan Z; Gómez JC; Mauriño E; Bai JC Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1112-7. PubMed ID: 16860613 [TBL] [Abstract][Full Text] [Related]
27. [Antitransglutaminase antibodies determination for the diagnosis of celiac disease]. Weitz JC; Montalva R; Alarcón T; Contreras L Rev Med Chil; 2003 Jan; 131(1):31-6. PubMed ID: 12643216 [TBL] [Abstract][Full Text] [Related]
28. [Antiendomysium antibodies and antigliadin antibodies in diagnosis and follow-up of celiac disease]. Cataldo F; Trippiedi MA; Marino V; Maltese I; Traverso G; Paternostro D; Albeggiani A Minerva Pediatr; 1993; 45(1-2):29-33. PubMed ID: 8316160 [TBL] [Abstract][Full Text] [Related]
29. [Relevance of anti-tissue transglutaminase antibodies in coeliac disease diagnosis]. Lepers S; Soula F; Fily S; Fontaine E; Vuye S; Colombel JF; Guimber D; Prin L; Dubucquoi S Ann Biol Clin (Paris); 2003; 61(3):337-43. PubMed ID: 12805013 [TBL] [Abstract][Full Text] [Related]
30. [The clinical significance of anti-gliadin antibodies determination in blood of children with suspected celiac diseases]. van der Meer BW; Mearin ML; Peña AS; van Tol MJ; Lamers CB; Dooren LJ Tijdschr Kindergeneeskd; 1993 Feb; 61(1):7-12. PubMed ID: 8493702 [TBL] [Abstract][Full Text] [Related]
31. Should stored serum of patients previously tested for celiac disease serology be retested for transglutaminase antibodies? Wengrower D; Doron D; Goldin E; Granot E J Clin Gastroenterol; 2006 Oct; 40(9):806-8. PubMed ID: 17016136 [TBL] [Abstract][Full Text] [Related]
32. Association between serum levels of total IgA and IgA class endomysial and antigliadin antibodies: implications for coeliac disease screening. Dickey W; McMillan SA; McCrum EE; Evans AE Eur J Gastroenterol Hepatol; 1997 Jun; 9(6):559-62. PubMed ID: 9222726 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of serological markers for celiac disease (IgA and IgG class antigliadin antibodies and IgA class antiendomysium antibodies) in patients with autoimmune rheumatologic diseases in Belo Horizonte, MG, Brazil. Koehne Vde B; Bahia M; Lanna CC; Pinto MR; Bambirra EA; Cunha AS Arq Gastroenterol; 2010; 47(3):250-6. PubMed ID: 21140085 [TBL] [Abstract][Full Text] [Related]
34. The natural history of gluten sensitivity: report of two new celiac disease patients resulting from a long-term follow-up of nonatrophic, first-degree relatives. Niveloni S; Pedreira S; Sugai E; Vazquez H; Smecuol E; Fiorini A; Cabanne A; Dezi R; Valero J; Kogan Z; Maurino E; Bai JC Am J Gastroenterol; 2000 Feb; 95(2):463-8. PubMed ID: 10685751 [TBL] [Abstract][Full Text] [Related]
35. The use of a single serological marker underestimates the prevalence of celiac disease in Israel: a study of blood donors. Shamir R; Lerner A; Shinar E; Lahat N; Sobel E; Bar-or R; Kerner H; Eliakim R Am J Gastroenterol; 2002 Oct; 97(10):2589-94. PubMed ID: 12385444 [TBL] [Abstract][Full Text] [Related]
36. [The usefulness of determining antigliadin IgA antibodies for the detection and follow-up of adult celiac disease]. Iglesias Picazo MR; Jiménez Alonso I; Melón Rey MA; Rodríguez Gómez S; Sánchez Alonso J; Villanueva Sánchez C; Pajares García JM Rev Esp Enferm Dig; 1992 Jan; 81(1):15-8. PubMed ID: 1547029 [TBL] [Abstract][Full Text] [Related]
37. IgA endomysium antibodies--an early predictor for celiac disease in children without villous atrophy. Grodzinsky E; Fälth-Magnusson K; Högberg L; Jansson G; Laurin P; Stenhammar L Acta Paediatr; 2008 Jul; 97(7):972-6. PubMed ID: 18489624 [TBL] [Abstract][Full Text] [Related]
38. [Antiendomysial antibodies: current role in the diagnosis of celiac disease compared to antigliadin antibodies]. Gemme G; Delogu A; Nobili F; Galeazzi G; Mariani P; Triglione P; Bonamico M Pediatr Med Chir; 1993; 15(6):595-7. PubMed ID: 8197021 [TBL] [Abstract][Full Text] [Related]
39. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Dickey W; Hughes DF; McMillan SA Am J Gastroenterol; 2000 Mar; 95(3):712-4. PubMed ID: 10710062 [TBL] [Abstract][Full Text] [Related]
40. [Increasing prevalence of celiac children with negative serum antigliadin antibodies]. Caristo E; Tognato E; Di Dio G; Rapa A; Fonio P Minerva Pediatr; 2010 Apr; 62(2):119-23. PubMed ID: 20440230 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]